Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome
NCT ID: NCT06879535
Last Updated: 2025-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
80 participants
OBSERVATIONAL
2022-03-28
2025-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
Does the main symptoms of the patients diagnosed with long COVID aproximate to those of patients who have had COVID acute infection without devoloping long COVID? Participants will answer mailed survey questions about their main symptons.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
NCT04814914
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159
Follow-up of Covid-19 Long Term Sequelae
NCT05097677
poSt Covid-19 Infection centraL Sensitisation 2
NCT04701892
Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain
NCT04355871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Patients diagnosed with long COVID
No interventions assigned to this group
Controls
Patients who have had COVID acute infection without developing long COVID
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who accepted to participate in the study
* patients who have had COVID acute infection
* patients who have long COVID (cases)
Exclusion Criteria
* patients whose diagnosis of long COVID was revoked during the study (cases)
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital del Rio Hortega
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrés Carrascosa Gil
Médico Licenciado Especialista en Anestesiología y Reanimación
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Río Hortega
Valladolid, Valladolid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-PI197
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.